Bagnato, Gianluca <br/><br/>
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.  [electronic resource] 

 -  Arthritis research & therapy  Sep 2013 
 - R120 p.  digital 
<br/><br/> Publication Type: Journal Article; Retracted Publication 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/ar4300  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--metabolism<br/>Animals<br/>Antithyroid Agents--pharmacology<br/>Blotting, Western<br/>Disease Models, Animal<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Female<br/>Fibrosis--complications<br/>Hypochlorous Acid<br/>Hypothyroidism--blood<br/>Immunohistochemistry<br/>Mice<br/>Mice, Inbred BALB C<br/>Muscle, Smooth--chemistry<br/>Oxidants<br/>Propylthiouracil--pharmacology<br/>Pulmonary Fibrosis--complications<br/>Random Allocation<br/>Scleroderma, Systemic--chemically induced<br/>Skin--drug effects<br/>Thyrotropin--blood<br/>Thyroxine--blood<br/>Triiodothyronine--blood<br/>Vascular Endothelial Growth Factor A--metabolism<br/>ras Proteins--metabolism